1 Introduction to Research & Analysis Reports
1.1 Osteoarthritis Gene Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Osteoarthritis Gene Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Osteoarthritis Gene Therapy Overall Market Size
2.1 Global Osteoarthritis Gene Therapy Market Size: 2022 VS 2029
2.2 Global Osteoarthritis Gene Therapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Osteoarthritis Gene Therapy Players in Global Market
3.2 Top Global Osteoarthritis Gene Therapy Companies Ranked by Revenue
3.3 Global Osteoarthritis Gene Therapy Revenue by Companies
3.4 Top 3 and Top 5 Osteoarthritis Gene Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Osteoarthritis Gene Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Osteoarthritis Gene Therapy Players in Global Market
3.6.1 List of Global Tier 1 Osteoarthritis Gene Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Osteoarthritis Gene Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Osteoarthritis Gene Therapy Market Size Markets, 2022 & 2029
4.1.2 Synovium Injection
4.1.3 Cartilage Injection
4.2 By Type – Global Osteoarthritis Gene Therapy Revenue & Forecasts
4.2.1 By Type – Global Osteoarthritis Gene Therapy Revenue, 2018-2023
4.2.2 By Type – Global Osteoarthritis Gene Therapy Revenue, 2024-2029
4.2.3 By Type – Global Osteoarthritis Gene Therapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Osteoarthritis Gene Therapy Market Size, 2022 & 2029
5.1.2 Hospitals and clinics
5.1.3 Orthopedic Centers
5.1.4 Assisted living Facilities
5.1.5 Nursing Homes
5.1.6 Ambulatory Surgical Centers
5.1.7 Others
5.2 By Application – Global Osteoarthritis Gene Therapy Revenue & Forecasts
5.2.1 By Application – Global Osteoarthritis Gene Therapy Revenue, 2018-2023
5.2.2 By Application – Global Osteoarthritis Gene Therapy Revenue, 2024-2029
5.2.3 By Application – Global Osteoarthritis Gene Therapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Osteoarthritis Gene Therapy Market Size, 2022 & 2029
6.2 By Region – Global Osteoarthritis Gene Therapy Revenue & Forecasts
6.2.1 By Region – Global Osteoarthritis Gene Therapy Revenue, 2018-2023
6.2.2 By Region – Global Osteoarthritis Gene Therapy Revenue, 2024-2029
6.2.3 By Region – Global Osteoarthritis Gene Therapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Osteoarthritis Gene Therapy Revenue, 2018-2029
6.3.2 US Osteoarthritis Gene Therapy Market Size, 2018-2029
6.3.3 Canada Osteoarthritis Gene Therapy Market Size, 2018-2029
6.3.4 Mexico Osteoarthritis Gene Therapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Osteoarthritis Gene Therapy Revenue, 2018-2029
6.4.2 Germany Osteoarthritis Gene Therapy Market Size, 2018-2029
6.4.3 France Osteoarthritis Gene Therapy Market Size, 2018-2029
6.4.4 U.K. Osteoarthritis Gene Therapy Market Size, 2018-2029
6.4.5 Italy Osteoarthritis Gene Therapy Market Size, 2018-2029
6.4.6 Russia Osteoarthritis Gene Therapy Market Size, 2018-2029
6.4.7 Nordic Countries Osteoarthritis Gene Therapy Market Size, 2018-2029
6.4.8 Benelux Osteoarthritis Gene Therapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Osteoarthritis Gene Therapy Revenue, 2018-2029
6.5.2 China Osteoarthritis Gene Therapy Market Size, 2018-2029
6.5.3 Japan Osteoarthritis Gene Therapy Market Size, 2018-2029
6.5.4 South Korea Osteoarthritis Gene Therapy Market Size, 2018-2029
6.5.5 Southeast Asia Osteoarthritis Gene Therapy Market Size, 2018-2029
6.5.6 India Osteoarthritis Gene Therapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Osteoarthritis Gene Therapy Revenue, 2018-2029
6.6.2 Brazil Osteoarthritis Gene Therapy Market Size, 2018-2029
6.6.3 Argentina Osteoarthritis Gene Therapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Osteoarthritis Gene Therapy Revenue, 2018-2029
6.7.2 Turkey Osteoarthritis Gene Therapy Market Size, 2018-2029
6.7.3 Israel Osteoarthritis Gene Therapy Market Size, 2018-2029
6.7.4 Saudi Arabia Osteoarthritis Gene Therapy Market Size, 2018-2029
6.7.5 UAE Osteoarthritis Gene Therapy Market Size, 2018-2029
7 Osteoarthritis Gene Therapy Companies Profiles
7.1 Flexion
7.1.1 Flexion Company Summary
7.1.2 Flexion Business Overview
7.1.3 Flexion Osteoarthritis Gene Therapy Major Product Offerings
7.1.4 Flexion Osteoarthritis Gene Therapy Revenue in Global Market (2018-2023)
7.1.5 Flexion Key News & Latest Developments
7.2 GeneQuine
7.2.1 GeneQuine Company Summary
7.2.2 GeneQuine Business Overview
7.2.3 GeneQuine Osteoarthritis Gene Therapy Major Product Offerings
7.2.4 GeneQuine Osteoarthritis Gene Therapy Revenue in Global Market (2018-2023)
7.2.5 GeneQuine Key News & Latest Developments
7.3 Novartis
7.3.1 Novartis Company Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Osteoarthritis Gene Therapy Major Product Offerings
7.3.4 Novartis Osteoarthritis Gene Therapy Revenue in Global Market (2018-2023)
7.3.5 Novartis Key News & Latest Developments
7.4 Smith & Nephew
7.4.1 Smith & Nephew Company Summary
7.4.2 Smith & Nephew Business Overview
7.4.3 Smith & Nephew Osteoarthritis Gene Therapy Major Product Offerings
7.4.4 Smith & Nephew Osteoarthritis Gene Therapy Revenue in Global Market (2018-2023)
7.4.5 Smith & Nephew Key News & Latest Developments
7.5 Genascence
7.5.1 Genascence Company Summary
7.5.2 Genascence Business Overview
7.5.3 Genascence Osteoarthritis Gene Therapy Major Product Offerings
7.5.4 Genascence Osteoarthritis Gene Therapy Revenue in Global Market (2018-2023)
7.5.5 Genascence Key News & Latest Developments
7.6 Kolon TissueGene
7.6.1 Kolon TissueGene Company Summary
7.6.2 Kolon TissueGene Business Overview
7.6.3 Kolon TissueGene Osteoarthritis Gene Therapy Major Product Offerings
7.6.4 Kolon TissueGene Osteoarthritis Gene Therapy Revenue in Global Market (2018-2023)
7.6.5 Kolon TissueGene Key News & Latest Developments
7.7 Sanofi
7.7.1 Sanofi Company Summary
7.7.2 Sanofi Business Overview
7.7.3 Sanofi Osteoarthritis Gene Therapy Major Product Offerings
7.7.4 Sanofi Osteoarthritis Gene Therapy Revenue in Global Market (2018-2023)
7.7.5 Sanofi Key News & Latest Developments
7.8 Paraxel
7.8.1 Paraxel Company Summary
7.8.2 Paraxel Business Overview
7.8.3 Paraxel Osteoarthritis Gene Therapy Major Product Offerings
7.8.4 Paraxel Osteoarthritis Gene Therapy Revenue in Global Market (2018-2023)
7.8.5 Paraxel Key News & Latest Developments
7.9 Medipost
7.9.1 Medipost Company Summary
7.9.2 Medipost Business Overview
7.9.3 Medipost Osteoarthritis Gene Therapy Major Product Offerings
7.9.4 Medipost Osteoarthritis Gene Therapy Revenue in Global Market (2018-2023)
7.9.5 Medipost Key News & Latest Developments
7.10 Mundipharma
7.10.1 Mundipharma Company Summary
7.10.2 Mundipharma Business Overview
7.10.3 Mundipharma Osteoarthritis Gene Therapy Major Product Offerings
7.10.4 Mundipharma Osteoarthritis Gene Therapy Revenue in Global Market (2018-2023)
7.10.5 Mundipharma Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Table 1. Osteoarthritis Gene Therapy Market Opportunities & Trends in Global Market
Table 2. Osteoarthritis Gene Therapy Market Drivers in Global Market
Table 3. Osteoarthritis Gene Therapy Market Restraints in Global Market
Table 4. Key Players of Osteoarthritis Gene Therapy in Global Market
Table 5. Top Osteoarthritis Gene Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Osteoarthritis Gene Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Osteoarthritis Gene Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Osteoarthritis Gene Therapy Product Type
Table 9. List of Global Tier 1 Osteoarthritis Gene Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Osteoarthritis Gene Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Osteoarthritis Gene Therapy Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Osteoarthritis Gene Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Osteoarthritis Gene Therapy Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Osteoarthritis Gene Therapy Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Osteoarthritis Gene Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Osteoarthritis Gene Therapy Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Osteoarthritis Gene Therapy Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Osteoarthritis Gene Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Osteoarthritis Gene Therapy Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Osteoarthritis Gene Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Osteoarthritis Gene Therapy Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Osteoarthritis Gene Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Osteoarthritis Gene Therapy Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Osteoarthritis Gene Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Osteoarthritis Gene Therapy Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Osteoarthritis Gene Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Osteoarthritis Gene Therapy Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Osteoarthritis Gene Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Osteoarthritis Gene Therapy Revenue, (US$, Mn), 2024-2029
Table 30. Flexion Company Summary
Table 31. Flexion Osteoarthritis Gene Therapy Product Offerings
Table 32. Flexion Osteoarthritis Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. Flexion Key News & Latest Developments
Table 34. GeneQuine Company Summary
Table 35. GeneQuine Osteoarthritis Gene Therapy Product Offerings
Table 36. GeneQuine Osteoarthritis Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. GeneQuine Key News & Latest Developments
Table 38. Novartis Company Summary
Table 39. Novartis Osteoarthritis Gene Therapy Product Offerings
Table 40. Novartis Osteoarthritis Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. Novartis Key News & Latest Developments
Table 42. Smith & Nephew Company Summary
Table 43. Smith & Nephew Osteoarthritis Gene Therapy Product Offerings
Table 44. Smith & Nephew Osteoarthritis Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. Smith & Nephew Key News & Latest Developments
Table 46. Genascence Company Summary
Table 47. Genascence Osteoarthritis Gene Therapy Product Offerings
Table 48. Genascence Osteoarthritis Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. Genascence Key News & Latest Developments
Table 50. Kolon TissueGene Company Summary
Table 51. Kolon TissueGene Osteoarthritis Gene Therapy Product Offerings
Table 52. Kolon TissueGene Osteoarthritis Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. Kolon TissueGene Key News & Latest Developments
Table 54. Sanofi Company Summary
Table 55. Sanofi Osteoarthritis Gene Therapy Product Offerings
Table 56. Sanofi Osteoarthritis Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. Sanofi Key News & Latest Developments
Table 58. Paraxel Company Summary
Table 59. Paraxel Osteoarthritis Gene Therapy Product Offerings
Table 60. Paraxel Osteoarthritis Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. Paraxel Key News & Latest Developments
Table 62. Medipost Company Summary
Table 63. Medipost Osteoarthritis Gene Therapy Product Offerings
Table 64. Medipost Osteoarthritis Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 65. Medipost Key News & Latest Developments
Table 66. Mundipharma Company Summary
Table 67. Mundipharma Osteoarthritis Gene Therapy Product Offerings
Table 68. Mundipharma Osteoarthritis Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 69. Mundipharma Key News & Latest Developments
List of Figures
Figure 1. Osteoarthritis Gene Therapy Segment by Type in 2022
Figure 2. Osteoarthritis Gene Therapy Segment by Application in 2022
Figure 3. Global Osteoarthritis Gene Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Osteoarthritis Gene Therapy Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Osteoarthritis Gene Therapy Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Osteoarthritis Gene Therapy Revenue in 2022
Figure 8. By Type - Global Osteoarthritis Gene Therapy Revenue Market Share, 2018-2029
Figure 9. By Application - Global Osteoarthritis Gene Therapy Revenue Market Share, 2018-2029
Figure 10. By Type - Global Osteoarthritis Gene Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Osteoarthritis Gene Therapy Revenue Market Share, 2018-2029
Figure 12. By Application - Global Osteoarthritis Gene Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Osteoarthritis Gene Therapy Revenue Market Share, 2018-2029
Figure 14. By Region - Global Osteoarthritis Gene Therapy Revenue Market Share, 2018-2029
Figure 15. By Country - North America Osteoarthritis Gene Therapy Revenue Market Share, 2018-2029
Figure 16. US Osteoarthritis Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Osteoarthritis Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Osteoarthritis Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Osteoarthritis Gene Therapy Revenue Market Share, 2018-2029
Figure 20. Germany Osteoarthritis Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 21. France Osteoarthritis Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Osteoarthritis Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Osteoarthritis Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Osteoarthritis Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Osteoarthritis Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Osteoarthritis Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Osteoarthritis Gene Therapy Revenue Market Share, 2018-2029
Figure 28. China Osteoarthritis Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Osteoarthritis Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Osteoarthritis Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Osteoarthritis Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 32. India Osteoarthritis Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Osteoarthritis Gene Therapy Revenue Market Share, 2018-2029
Figure 34. Brazil Osteoarthritis Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Osteoarthritis Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Osteoarthritis Gene Therapy Revenue Market Share, 2018-2029
Figure 37. Turkey Osteoarthritis Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Osteoarthritis Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Osteoarthritis Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Osteoarthritis Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 41. Flexion Osteoarthritis Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. GeneQuine Osteoarthritis Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Novartis Osteoarthritis Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Smith & Nephew Osteoarthritis Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Genascence Osteoarthritis Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Kolon TissueGene Osteoarthritis Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Sanofi Osteoarthritis Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Paraxel Osteoarthritis Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Medipost Osteoarthritis Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Mundipharma Osteoarthritis Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
